IREN

IREN Limited

There isn't enough reported data to score IREN yet.

MC

Moelis & Company

58
Fundamentals58/ 100
Valuation59/ 100
Upside potential77/ 100
Risk potential13/ 100

MC's fundamentals are mixed: revenue grew 14%, but earnings per share fell 1.7%. At 19x earnings, it's trading in line with its usual 21x. Analysts expect strong earnings growth, though they disagree widely on how much.

IREN Fundamentals

MetricStatus
Under pressure
Weak
N/A
N/A

IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.

MC Fundamentals

MetricStatus
Stable
Healthy
N/A
N/A

MC's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MC.

IREN PE Valuation

IREN has no meaningful PE right now: it lost money over the past year.

MC PE Valuation

CHEAPFAIREXPENSIVE125x251x376x502x
CHEAPFAIREXPENSIVE125x251x376x502x
LevelPEPriceVs current
Cheap12x$35.85-36%
Forward16x$56.01—
Current19x$56.01—
Fair20x$60.15+7.4%
Expensive38x$112+101%

Historical ranges are pointers, not guarantees.

MC's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 16x next year's earnings.

IREN Forward outlook

MetricOutlook
--
Losses growing
Strong growth
Strongly improving
Limited
Low

Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.

MC Forward outlook

MetricOutlook
Improving
Strong growth
Strong growth
Improving
Limited
Low

MC has the edge over IREN on the outlook, with more favorable earnings expectations.

IREN Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $19.48 on Nov 12.

There is not enough scenario data to compare IREN and MC's risk to reward.

MC Risk to reward

ScenarioChangePrice
Upside+44%$80.41
Downside-13%$48.79

Calculated from the latest close: $56.01 on Nov 12.

There is not enough scenario data to compare IREN and MC's risk to reward.

IREN Earnings Per Share

Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
QuarterTTM EPSYoY
Q3 2026-$3.96-347%
Q2 2026-$2.22-988%
Q1 2026$0.51+$1.10
Q4 2025$1.18+$1.62
Q3 2025$1.60+$1.99
Q2 2025$0.25+$0.45
Q1 2025-$0.59-$0.43
Q4 2024-$0.44-$0.15

IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.

MC Earnings Per Share

Q4 2023: $-0.36Q1 2024: $-0.19Q2 2024: $0.15Q3 2024: $0.53Q4 2024: $1.76Q1 2025: $2.18Q2 2025: $2.54Q3 2025: $2.99Q4 2025: $2.94Q1 2026: $2.78Q2 2026: $2.87Q3 2026: $2.94Forward: $3.55
Q4 2023: $-0.36Q1 2024: $-0.19Q2 2024: $0.15Q3 2024: $0.53Q4 2024: $1.76Q1 2025: $2.18Q2 2025: $2.54Q3 2025: $2.99Q4 2025: $2.94Q1 2026: $2.78Q2 2026: $2.87Q3 2026: $2.94Forward: $3.55
QuarterTTM EPSYoY
Forward$3.55+21%
Q3 2026$2.94-1.7%
Q2 2026$2.87+13%
Q1 2026$2.78+28%
Q4 2025$2.94+67%
Q3 2025$2.99+464%
Q2 2025$2.54+1593%
Q1 2025$2.18+$2.37
Q4 2024$1.76+$2.12

MC has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.

IREN Quarterly Revenue

Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
QuarterRevenueYoY
Q3 2026$228M-5.1%
Q2 2026$137.2M-27%
Q1 2026$144.8M0%
Q4 2025$184.7M+59%
Q3 2025$240.3M+355%
Q2 2025$187.3M+230%
Q1 2025$144.8M+168%
Q4 2024$116.1M+176%

IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.

MC Quarterly Revenue

Q4 2023: $215MQ1 2024: $217MQ2 2024: $265MQ3 2024: $274MQ4 2024: $439MQ1 2025: $307MQ2 2025: $365MQ3 2025: $357MQ4 2025: $488MQ1 2026: $320MQ2 2026: $409MQ3 2026: --
Q4 2023: $215MQ1 2024: $217MQ2 2024: $265MQ3 2024: $274MQ4 2024: $439MQ1 2025: $307MQ2 2025: $365MQ3 2025: $357MQ4 2025: $488MQ1 2026: $320MQ2 2026: $409MQ3 2026: --
QuarterRevenueYoY
Q2 2026$409.4M+12%
Q1 2026$319.8M+4.3%
Q4 2025$487.9M+11%
Q3 2025$356.9M+30%
Q2 2025$365.4M+38%
Q1 2025$306.6M+41%
Q4 2024$438.7M+104%
Q3 2024$273.8M+0.6%

MC's revenue has grown year over year for 12 quarters in a row: $409M last quarter, up 12% from the same quarter a year ago.

IREN Free Cash Flow

Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
QuarterFree cash flowYoY
Q3 2026-$1.6B-$1.6B
Q2 2026$482.2M+2895%
Q1 2026-$873.8M-$523.1M
Q4 2025-$468M-$334M
Q3 2025-$38M+$349.4M
Q2 2025$16.1M+$179M
Q1 2025-$350.7M-$128.7M
Q4 2024-$134M-$105.2M

IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.

MC Free Cash Flow

Q4 2023: $94MQ1 2024: −$170MQ2 2024: $138MQ3 2024: $135MQ4 2024: $313MQ1 2025: −$169MQ2 2025: $199MQ3 2025: $180MQ4 2025: $330MQ1 2026: −$292MQ2 2026: $218MQ3 2026: $250M
Q4 2023: $94MQ1 2024: −$170MQ2 2024: $138MQ3 2024: $135MQ4 2024: $313MQ1 2025: −$169MQ2 2025: $199MQ3 2025: $180MQ4 2025: $330MQ1 2026: −$292MQ2 2026: $218MQ3 2026: $250M
QuarterFree cash flowYoY
Q3 2026$250.2M+39%
Q2 2026$218M+9.3%
Q1 2026-$291.6M-$123M
Q4 2025$329.6M+5.3%
Q3 2025$179.6M+33%
Q2 2025$199.4M+45%
Q1 2025-$168.6M+$1.8M
Q4 2024$313M+233%

MC has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.

IREN Total Shares

Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
PeriodChange %Net change
Quarterly+26%+82.4M shares
1 year+10%+36.9M shares
3 years+511%+333M shares
5 years+624%+344M shares
Available history+2346%+382M shares

IREN has 399M diluted shares, up 10% from a year ago.

MC Total Shares

Q4 2023: 69MQ1 2024: 75MQ2 2024: 76MQ3 2024: 77MQ4 2024: 78MQ1 2025: 79MQ2 2025: 79MQ3 2025: 79MQ4 2025: 80MQ1 2026: 79MQ2 2026: 79MQ3 2026: 78M
Q4 2023: 69MQ1 2024: 75MQ2 2024: 76MQ3 2024: 77MQ4 2024: 78MQ1 2025: 79MQ2 2025: 79MQ3 2025: 79MQ4 2025: 80MQ1 2026: 79MQ2 2026: 79MQ3 2026: 78M
PeriodChange %Net change
Quarterly-1.7%-1.4M shares
1 year-1.3%-994K shares
3 years+14%+9.3M shares
5 years+14%+9.8M shares
Available history+39%+21.7M shares

MC has the edge over IREN on shareholder dilution, with a more favorable share count trend.

IREN Net Leverage

Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
QuarterNet LeverageStatus
Q1 2026157.6xHigh
Q4 202522.2xHigh
Q3 20254.1xHigh
Q2 20252.0xModerate
Q1 20253.3xElevated
Q4 2024-4.6xNet Cash
Q3 2024-16.7xNet Cash
Q2 2024-15.9xNet Cash

IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.

MC Net Leverage

Q2 2024: 10.5xQ3 2024: 1.6xQ4 2024: -1.0xQ1 2025: 0.2xQ2 2025: -0.0xQ3 2025: -0.1xQ4 2025: -0.8xQ1 2026: 0.4xQ2 2026: 0.2xQ3 2026: -0.5x
Q2 2024: 10.5xQ3 2024: 1.6xQ4 2024: -1.0xQ1 2025: 0.2xQ2 2025: -0.0xQ3 2025: -0.1xQ4 2025: -0.8xQ1 2026: 0.4xQ2 2026: 0.2xQ3 2026: -0.5x
QuarterNet LeverageStatus
Q3 2026-0.5xNet Cash
Q2 20260.2xVery low
Q1 20260.4xVery low
Q4 2025-0.8xNet Cash
Q3 2025-0.1xNet Cash
Q2 2025-0.0xNet Cash
Q1 20250.2xVery low
Q4 2024-1.0xNet Cash

MC has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MC.

IREN Weekly Momentum

MetricValueStatus
RSI33.3Neutral
Stochastic8.2Oversold

IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).

MC Weekly Momentum

MetricValueStatus
RSI38.7Neutral
Stochastic30.3Neutral

MC's weekly RSI is 39 (neutral) and its Stochastic is 30 (neutral).

IREN PE vs Financial Services Sector

MetricIRENSector medianRelative
PEN/A13x—

IREN has no meaningful PE right now: it lost money over the past year.

MC PE vs Financial Services Sector

MetricMCSector medianRelative
PE19x13x46% above
PE %446319 pts below

MC is trading at 19x earnings, a 46% premium to the Financial Services sector's median of 13x.

IREN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.835% below
20 week MA$36.246% below
50 week MA$42.854% below
100 week MA$32.039% below
200 week MA$19.12.1% above

IREN has the edge over MC on trend strength, trading above more of its moving averages.

MC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$56.61% below
20 week MA$62.610% below
50 week MA$64.513% below
100 week MA$65.314% below
200 week MA$59.05.1% below

MC is in a downtrend: it's below all five of its weekly moving averages, and 5.1% below its 200-week average.

IREN Yearly ROI

YearStart priceEnd priceROI
2021$24.8$17.2-31%
2022$17.2$1.19-93%
2023$1.19$7.15+501%
2024$7.15$10.7+50%
2025$10.7$40.3+276%
2026 YTD$40.3$19.5-52%

IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.

MC Yearly ROI

YearStart priceEnd priceROI
2020$32.8$47.2+44%
2021$47.2$62.4+32%
2022$62.4$39.0-37%
2023$39.0$56.1+44%
2024$56.1$74.5+33%
2025$74.5$71.6-3.9%
2026 YTD$71.6$56.0-22%

MC has the edge over IREN on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key